99% Pure | Multi Dose | Finished in the USA Mazdutide peptide is an emerging dual GLP-1/GCG receptor agonist peptide under investigation for incretin and glucagon receptor signalling, glucose metabolism, and insulin sensitivity. As part of the next generation of metabolic-focused peptides, Mazdutide is studied for its synergistic activation of glucagon and GLP-1 receptors, which are examined in lipid-oxidation and energy-expenditure pathway research.
Commonly referred to as a “next-gen GLP-1 analog,” Mazdutide peptide is quickly gaining attention in the research community—especially in models studying obesity, type 2 diabetes, and metabolic syndrome in men.

